Coronary Artery Disease (CAD)
Cardiovascular disease (CVD), including heart disease and stroke, is the leading cause of death worldwide, accounting for 17.7 million deaths annually, or approximately one-third of all deaths globally.
Learn more about CAD and the future of biomarker-based clinical research
THE NEED FOR PERSONALISED THERAPY IN CAD
Studies are beginning to unravel the potential of personalised medicine in patients with CAD, in that targeting inflammation in those with residual inflammatory risk appears to be a viable strategy for ensuring that the right patients receive the right therapy at the right time. Learn more here >>